Microbiology

bioMérieux Canada, AMMI Canada, EPIC and AMR-One Health Consortium co-host the second Canadian symposium to fight antimicrobial resistance

Retrieved on: 
Wednesday, November 22, 2023
Ministry, EPIC, Global health, Research, Emerging, Microbiology, WHO, OHC, Risk, Disease, One Health, MaRS Discovery District, Infection, Death, Pharmacology, AMR, Diagnosis, Software, Medical microbiology, Veterinary medicine, Physician, Legislation, Public, Education, Ministry of Health, Medical device, Pharmaceutical industry, Health

This scientific summit aims to identify concrete actions to combat antimicrobial resistance while highlighting Canadian research and leadership in this crucial fight.

Key Points: 
  • This scientific summit aims to identify concrete actions to combat antimicrobial resistance while highlighting Canadian research and leadership in this crucial fight.
  • "Infectious Diseases physicians, medical microbiologists and clinical microbiologists are actively involved in research, innovation and education to combat antimicrobial resistance.
  • A One Health approach in line with the Pan-Canadian Action Plan to combat AMR is a priority"," says Dr. Deborah Yamamura, President of AMMI Canada.
  • Several discussions will also focus on the One Health approach, which, with its collaborative cross-disciplinary and cross-sector approach, is essential in the fight against antimicrobial resistance.

Zymo Research Announces Sponsorship of the Inaugural Microbes in Wastewater Symposium

Retrieved on: 
Tuesday, November 21, 2023
NSF, Research, Engineering, Microbiology, Waterborne diseases, Collection, Marketing, AMR, University, Infection, NGS, University of California, Environmental health

IRVINE, Calif., Nov. 21, 2023 /PRNewswire/ -- Zymo Research Corporation proudly announced its sponsorship of the upcoming "Microbes in Wastewater: Molecular Approaches in Pathogen and AMR Surveillance" symposium, scheduled for January 18th -19th, 2024, in Laguna Beach, California.

Key Points: 
  • IRVINE, Calif., Nov. 21, 2023 /PRNewswire/ -- Zymo Research Corporation proudly announced its sponsorship of the upcoming "Microbes in Wastewater: Molecular Approaches in Pathogen and AMR Surveillance" symposium, scheduled for January 18th -19th, 2024, in Laguna Beach, California.
  • The aim is to foster conversations on technologies and methods for the standardization of wastewater testing and surveillance.
  • Zymo Research's sponsorship emphasizes its dedication to advancing scientific knowledge in wastewater research while stressing the importance of public and environmental health.
  • Attendees are invited to explore Zymo Research's booth to learn about cutting-edge solutions enhancing molecular approaches in wastewater research.

Rosalind Franklin University Announces New Director of Center for Genetic Diseases

Retrieved on: 
Thursday, November 16, 2023
Cell biology, Research, Loyola University Medical Center, Microbiology, Cornell University, Student, Multimedia, DSM-IV codes, RFU, Messenger, Therapy, NIH, University, Doctor of Philosophy, Washington State University, Genetic disorder, RNA, COVID, Science

NORTH CHICAGO, Ill., Nov. 16, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announces the appointment of molecular biologist Weihang "Valerie" Chai, PhD, as director of the Center for Genetic Diseases .

Key Points: 
  • NORTH CHICAGO, Ill., Nov. 16, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announces the appointment of molecular biologist Weihang "Valerie" Chai, PhD, as director of the Center for Genetic Diseases .
  • "She's the ideal person to build the center along new directions — approaching genetic diseases, in part, through a focus on cancer research.
  • Previously, she was a tenured associate professor for the Elson S. Floyd College of Medicine at Washington State University.
  • She earned her doctorate in microbiology from Cornell University and completed a postdoctoral fellowship in cell biology at the University of Texas Southwestern Medical Center at Dallas.

Cytonus expands its Scientific Advisory Board with Oncolytic Virus expert John C. Bell, PhD

Retrieved on: 
Thursday, November 16, 2023
Royal Society, ISCB Senior Scientist Award, Research, Therapy, Potyvirus, Ottawa Hospital Research Institute, Immunology, McGill University, Vaccine, Royal, Bell, Science, University, Cancer, Virus, Outline of health sciences, McMaster University, Doctor of Philosophy, Microbiology, Medical Research Council, University of Ottawa, Pharmaceutical industry, Management, Medicine, Biochemistry, MD

SAN DIEGO, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Cytonus Therapeutics, Inc., announced today that the company has expanded its Scientific Board of Advisors with the appointment of University of Ottawa Professor and pioneering researcher in the field of oncolytic viruses John C. Bell, PhD.

Key Points: 
  • Board Expansion for Cytonus Therapeutics, Inc.
    SAN DIEGO, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Cytonus Therapeutics, Inc., announced today that the company has expanded its Scientific Board of Advisors with the appointment of University of Ottawa Professor and pioneering researcher in the field of oncolytic viruses John C. Bell, PhD.
  • "It is a great privilege for Cytonus to be joined by Professor Bell, who is an international leader in the field of modern viral immunotherapeutics."
  • commented Cytonus' cofounder and Chief Scientific Innovator, Richard Klemke, PhD.
  • Cytonus' Scientific Advisory Board is comprised of accomplished business leaders, distinguished research scientists, and key opinion leaders from prestigious academic institutions, immune-oncology centers, cell therapy centers, and private industry.

New Report Outlines Microbial Solutions to Mediate Methane Emissions

Retrieved on: 
Wednesday, November 15, 2023
American Society for Microbiology, Carbon, Climate change, Sheep, Greenhouse, American Academy, American Geophysical Union, Multimedia, Climate, Methane emissions, Animal, ASM, Methane, Society, Knowledge, Role, Publication, Nursing, Microorganism, Microbiology

The report highlights recommendations to further the scientific community's understanding of microbial processes of methane production and consumption to mitigate methane emissions and address climate change.

Key Points: 
  • The report highlights recommendations to further the scientific community's understanding of microbial processes of methane production and consumption to mitigate methane emissions and address climate change.
  • Microbes are major consumers and producers of methane, so understanding the diverse metabolic capabilities of microbes can help scientists better develop microbial solutions that address the issue of methane emissions.
  • The recommendations in the report aim to help advance the development of solutions that leverage microbes to mediate methane emissions from 4 main sources: enteric fermentation in ruminant animals (such as cows or sheep), animal wastes, rice paddies and landfills.
  • To complement the new report and serve as a practical next step, ASM will release a Microbial Methane Mitigation research roadmap in December, outlining current knowledge gaps and first-order research priorities for experts to use microbes to combat increasing methane emissions.

L'ORÉAL USA ANNOUNCES 2023 FOR WOMEN IN SCIENCE AWARDEES, MARKING 20-YEAR COMMITMENT TO WOMEN IN STEM

Retrieved on: 
Monday, November 13, 2023
Woman, Biomedical engineering, Engineering, Gladstone Institutes, NASEM, Infection, Uterus, Johns Hopkins University, Uterine fibroid, Fibrosis, Fertility, Gene editing, Data science, Diplomacy, Health, National academy, Neuroscience, Ageing, California Institute of Technology, Communication, Brain cell, Female, Spina bifida, AAAS, Medicine, Physics, Khwarizmi International Award, DSM-IV codes, Mentorship, Equity, Animal, University, Bangladesh Technical Education Board, University of North Carolina, Cell, UNESCO, Brain, Research, Microbiology, Biotechnology, Fungus, Fellow, CBS, Human, Survival, Neoplasm, Biology, Pharmaceutical industry, Management, STEM, Science

NEW YORK, Nov. 13, 2023 /PRNewswire/ -- Today, L'Oréal USA announced the recipients of its 2023 For Women in Science (FWIS) Fellowship program, which grants awards annually to five female postdoctoral scientists to support their research endeavors. This year marks L'Oréal USA's 20th anniversary of helping to advance women in STEM fields through its FWIS program, which has provided more than $5 million in grants to support the work of innovative women scientists.

Key Points: 
  • "L'Oréal USA is proud to recognize this 20th Anniversary milestone of the For Women in Science program.
  • The L'Oréal USA FWIS philanthropic program embodies L'Oréal's fundamental belief in the indispensable connection between science and women.
  • The L'Oréal USA program includes a requirement to ensure recipients are committed to serving as role models for younger generations.
  • For more information about the L'Oréal USA 2023 For Women in Science Fellows or to apply for the L'Oréal For Women in Science 2024 program, please visit: loreal.com/en/usa/pages/group/fwis/ .

Rasha Maal-Bared Joins CDM Smith as Principal Environmental Scientist

Retrieved on: 
Wednesday, November 8, 2023
Laboratory, Applied ecology, Water, Drainage, Research, CDM, Engineering, Environment, Transport, COVID-19, Microbiology, CDM Smith, Canada, Climate change, Management

Burnaby, BRITISH COLUMBIA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- CDM Smith is pleased to announce the addition of Rasha Maal-Bared PhD, P Biol, RMCCM, an internationally recognized microbiologist, to the firm as a principal environmental scientist.

Key Points: 
  • Burnaby, BRITISH COLUMBIA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- CDM Smith is pleased to announce the addition of Rasha Maal-Bared PhD, P Biol, RMCCM, an internationally recognized microbiologist, to the firm as a principal environmental scientist.
  • Notably, she played a pivotal role in synthesizing and simplifying COVID-19 information for the water community, aiding utility decision-making.
  • "We are thrilled to add a scientist of Rasha's caliber to our firm," said Lisa Forrest, CDM Smith senior vice president and environmental services group director.
  • CDM Smith is a privately owned engineering and construction firm providing legendary client service and smart solutions in water, environment, transportation, energy, and facilities.

AI Revolutionizes HBV Vaccine Development as Global Market Grows at a CAGR of 5.33% - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 9, 2023
Technology, Infectious Diseases, Health, Artificial Intelligence, WHO, Bioinformatics, LG Chem, Drug design, Intelligence, Composition, Incidence, Pregnancy, Vaccine, Government, ROW, Prevalence, Indian Immunologicals Limited, GSK plc, Merck, Data science, Mother, Vaccination, Liver cancer, Genomics, Transport, COVAX, COVID-19, Antibody, KM, Microbiology, Machine learning, Biochemistry, Blood, Hepatitis A and B vaccine, Serum, Hepatitis B virus, Public, Sanofi, Hepatitis, Hepatitis B, Immunization, Pediatrics, World Health Organization's response to the COVID-19 pandemic, Compound annual growth rate, HBV, Parent, Cirrhosis, Merck & Co.

The HBV vaccine stands as a crucial tool in the World Health Organization's (WHO) mission to eliminate HBV by 2030.

Key Points: 
  • The HBV vaccine stands as a crucial tool in the World Health Organization's (WHO) mission to eliminate HBV by 2030.
  • Since the approval of the first HBV vaccine in 1981, significant advancements have occurred in the development of HBV vaccines.
  • The United States leads the global market due to a high demand for the HBV vaccine, driven by ongoing HBV infection threats.
  • The integration of AI in vaccine and drug design is poised to accelerate vaccine development, enhance efficacy, and drive the HBV vaccine market's growth.

QNTM Labs Announces EU-GMP Certified Expansion to Meet Growing Industry Needs

Retrieved on: 
Tuesday, November 7, 2023
Mettler Toledo, Certification, Drug development, Mass spectrometry, Trust, Microbiology, Agilent Technologies, GMP, EU, Chromatography, Fine chemical

ODENSE, Denmark, Nov. 7, 2023 /PRNewswire/ -- QNTM Labs is pleased to announce the significant expansion to its existing headquarters.

Key Points: 
  • ODENSE, Denmark, Nov. 7, 2023 /PRNewswire/ -- QNTM Labs is pleased to announce the significant expansion to its existing headquarters.
  • This expansion serves as a testament to the trust and success accrued from client engagements since the initial GMP certification.
  • Cornelius Merlini, Managing Partner at Intrinsic Capital Partners, reflects, "QNTM Labs' expanded EU-GMP certifications showcase their unwavering commitment to quality and compliance.
  • With this expansion, QNTM Labs is better positioned to address the evolving analytical requirements of the pharmaceutical industry, both within Denmark and across the broader European market.

QNTM Labs Announces EU-GMP Certified Expansion to Meet Growing Industry Needs

Retrieved on: 
Tuesday, November 7, 2023
Mettler Toledo, Certification, Drug development, Mass spectrometry, Trust, Microbiology, Agilent Technologies, GMP, EU, Chromatography, Fine chemical

ODENSE, Denmark, Nov. 7, 2023 /PRNewswire/ -- QNTM Labs is pleased to announce the significant expansion to its existing headquarters.

Key Points: 
  • ODENSE, Denmark, Nov. 7, 2023 /PRNewswire/ -- QNTM Labs is pleased to announce the significant expansion to its existing headquarters.
  • This expansion serves as a testament to the trust and success accrued from client engagements since the initial GMP certification.
  • Cornelius Merlini, Managing Partner at Intrinsic Capital Partners, reflects, "QNTM Labs' expanded EU-GMP certifications showcase their unwavering commitment to quality and compliance.
  • With this expansion, QNTM Labs is better positioned to address the evolving analytical requirements of the pharmaceutical industry, both within Denmark and across the broader European market.